Mankind Pharma Limited IPO
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products. In India, the business is active in a number of acute and chronic therapeutic fields, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. Now is Listing IPO in NSE, BSE.
Event |
Minimum |
Maximum |
Lot |
1 |
14 |
Shares |
13 |
182 |
Amount |
₹14,040 |
₹1,96,560 |
Company Name |
Symbol |
Listing Exchange |
Issue Size |
IPO Open Date |
IPO Closing Date |
IPO Listing Date |
Mankind Pharma Limited |
MANKIND |
NSE, BSE |
2,80,41,192
|
25 Apr 23 |
27 Apr 23 |
08 May 23 |
Face Value |
Pre Issue Share Holding |
Post Issue Share Holding |
Allotment Date |
Refunds Date |
Shares Credit in demat Date |
₹1 per share |
79.00% |
76.50% |
03 May 23 |
04 May 23 |
05 May 23 |
No comments:
Post a Comment